Our human Organ-on-a-chip platform is first of its kind
Human Inner Ear-on-a-Chip
The BLB (Blood-Labyrinth Barrier) Platform is a first-in-class organ-on-a-chip technology that replicates the human inner ear’s selective barrier. Built to close the gap between promising preclinical data and clinical success, our dynamic model empowers drug developers to test, refine, and de-risk compounds—long before they reach the clinic.
Why it matters?
Most preclinical models miss the mark. By using human-derived cells and simulating real inner ear physiology, it brings clarity to complex drug behaviors—helping to fail early, or succeed faster.
Key Benefits:
Human relevance
Built with primary human cells to closely simulate the inner ear’s BLB.
Advanced technology
Patented dual-compartment chip supports up to 7 parallel experiments with automated handling. Standardized, recyclable design compatible with existing lab systems.
Automated chip handling
Integrated system with environmental control for temperature and flow conditions, ensuring reproducibility and stability across experiments.
Customizable testing
Supports key assays like barrier permeability (FITC-dextran), cell toxicity (LDH), and barrier integrity (TEER), plus custom protocols including active transport, HPLC profiling, and ototoxicity testing.
Our platform helps pharmaceutical developers de-risk early decisions, reduce costs, and accelerate the path to clinical success.
Leveraging our proprietary platform, we aim to develop the nasal chip entirely in-house as part of our expanding organ-on-a-chip portfolio
Our Team
Dedication. Expertise. Passion.
